ContraFect (NASDAQ:CFRX) Lifted to Sell at StockNews.com

StockNews.com upgraded shares of ContraFect (NASDAQ:CFRX – Get Rating) to a sell rating in a research note issued to investors on Monday. ContraFect Price Performance ContraFect stock opened at $1.18 on Monday. The company has a market capitalization of $1.85 million, a PE ratio of -0.01 and a beta of 0.43. ContraFect has a one […]

Related Keywords

,White Pine Capital ,Envestnet Asset Management Inc ,Contrafect Corp ,Goldman Sachs Group Inc ,Vanguard Group Inc ,Get Rating ,Sachs Group ,Asset Management ,Street Corp ,Pine Capital ,Gram Negative Lysins ,Contrafect Daily ,Contrafect ,Nasdaq Cfrx ,Cfrx ,Medical ,Upgrade ,Stocknews Com ,